PEP0021
Invitrogen™ Human DR5 Synthetic Peptide
Manufacturer: Invitrogen™
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PEP0021-Each-of-1 | In Stock | ₹ 16,247.84 |
PEP0021 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 16,247.84
GST (18%): ₹ 2,924.611
Total Price: ₹ 19,172.451
Gene ID (Entrez)
8795
Purification Method
purified
Common Name
Human DR5
Content And Storage
-20°C
Format
Liquid
For Use With (Application)
Blocking Assay, Control
Lyophilized
No
Product Type
Peptide
Regulatory Status
RUO - research use only
Species
Human
Accession Number
O14763
Concentration
200 μg/mL
Description
Synthetic Peptide
Formulation
PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
Gene Symbol
TNFRSF10B
Preservative
0.02% sodium azide
Quantity
50 μg
Storage Buffer
PBS
Related Products
Description
- DR5 Synthetic Peptide, PEP-0021, from Invitrogen
- DR5 (Apo2, TRAIL-R2, TRICK2, KILLER) is a recently identified death domain containing receptor for TRAIL, which mediates TRAIL induced apoptosis
- DR5 is a member of the TNF-receptor superfamily, and contains an intracellular death domain
- DR5 can be activated by tumor necrosis factor-related apoptosis inducing ligand (TNFSF10/TRAIL/APO-2L), and transduces an apoptosis signal
- Studies with FADD-deficient mice suggested that FADD, a death domain containing adaptor protein, is required for the apoptosis mediated by DR5
- Two transcript variants encoding different isoforms of DR5 and one non-coding transcript have been found
- Overexpression of DR5 induces apoptosis and activates NF-kappa-B
- DR5 is expressed in a number of cell types, and to particularly high levels in lymphocytes and spleen
- Diseases associated with DR5 dysfunction include squamous cell carcinoma, and diffuse infiltrative lymphocytosis syndrome
- This peptide corresponds to 20 amino acids near the carboxy terminus of human DR5.PEP-0021 can be used as a blocking peptide with polyclonal antibody PA5-19895.
Compare Similar Items
Show Difference
Gene ID (Entrez): 8795
Purification Method: purified
Common Name: Human DR5
Content And Storage: -20°C
Format: Liquid
For Use With (Application): Blocking Assay, Control
Lyophilized: No
Product Type: Peptide
Regulatory Status: RUO - research use only
Species: Human
Accession Number: O14763
Concentration: 200 μg/mL
Description: Synthetic Peptide
Formulation: PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
Gene Symbol: TNFRSF10B
Preservative: 0.02% sodium azide
Quantity: 50 μg
Storage Buffer: PBS
Gene ID (Entrez):
8795
Purification Method:
purified
Common Name:
Human DR5
Content And Storage:
-20°C
Format:
Liquid
For Use With (Application):
Blocking Assay, Control
Lyophilized:
No
Product Type:
Peptide
Regulatory Status:
RUO - research use only
Species:
Human
Accession Number:
O14763
Concentration:
200 μg/mL
Description:
Synthetic Peptide
Formulation:
PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
Gene Symbol:
TNFRSF10B
Preservative:
0.02% sodium azide
Quantity:
50 μg
Storage Buffer:
PBS
Gene ID (Entrez): 8793
Purification Method: purified
Common Name: Human CD264 (TRAIL-R4)
Content And Storage: -20°C
Format: Liquid
For Use With (Application): Blocking Assay, Control
Lyophilized: No
Product Type: Peptide
Regulatory Status: RUO - research use only
Species: Human
Accession Number: Q9UBN6
Concentration: 200 μg/mL
Description: Synthetic Peptide
Formulation: PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
Gene Symbol: TNFRSF10D
Preservative: 0.02% sodium azide
Quantity: 50 μg
Storage Buffer: PBS
Gene ID (Entrez):
8793
Purification Method:
purified
Common Name:
Human CD264 (TRAIL-R4)
Content And Storage:
-20°C
Format:
Liquid
For Use With (Application):
Blocking Assay, Control
Lyophilized:
No
Product Type:
Peptide
Regulatory Status:
RUO - research use only
Species:
Human
Accession Number:
Q9UBN6
Concentration:
200 μg/mL
Description:
Synthetic Peptide
Formulation:
PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
Gene Symbol:
TNFRSF10D
Preservative:
0.02% sodium azide
Quantity:
50 μg
Storage Buffer:
PBS
Gene ID (Entrez): 102
Purification Method: purified
Common Name: Human ADAM10
Content And Storage: -20°C
Format: Liquid
For Use With (Application): Blocking Assay, Control
Lyophilized: No
Product Type: Peptide
Regulatory Status: RUO - research use only
Species: Human
Accession Number: O14672
Concentration: 200 μg/mL
Description: Synthetic Peptide
Formulation: PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
Gene Symbol: ADAM10
Preservative: 0.02% sodium azide
Quantity: 50 μg
Storage Buffer: PBS
Gene ID (Entrez):
102
Purification Method:
purified
Common Name:
Human ADAM10
Content And Storage:
-20°C
Format:
Liquid
For Use With (Application):
Blocking Assay, Control
Lyophilized:
No
Product Type:
Peptide
Regulatory Status:
RUO - research use only
Species:
Human
Accession Number:
O14672
Concentration:
200 μg/mL
Description:
Synthetic Peptide
Formulation:
PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
Gene Symbol:
ADAM10
Preservative:
0.02% sodium azide
Quantity:
50 μg
Storage Buffer:
PBS
Gene ID (Entrez): 1777
Purification Method: purified
Common Name: Human DNase II
Content And Storage: -20°C
Format: Liquid
For Use With (Application): Blocking Assay, Control
Lyophilized: No
Product Type: Peptide
Regulatory Status: RUO - research use only
Species: Human
Accession Number: O00115
Concentration: 200 μg/mL
Description: Synthetic Peptide
Formulation: PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
Gene Symbol: DNASE2
Preservative: 0.02% sodium azide
Quantity: 50 μg
Storage Buffer: PBS
Gene ID (Entrez):
1777
Purification Method:
purified
Common Name:
Human DNase II
Content And Storage:
-20°C
Format:
Liquid
For Use With (Application):
Blocking Assay, Control
Lyophilized:
No
Product Type:
Peptide
Regulatory Status:
RUO - research use only
Species:
Human
Accession Number:
O00115
Concentration:
200 μg/mL
Description:
Synthetic Peptide
Formulation:
PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
Gene Symbol:
DNASE2
Preservative:
0.02% sodium azide
Quantity:
50 μg
Storage Buffer:
PBS